Clinical Demand/Supply Planning Intern (Graduate) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 19 hours ago

Clinical Demand/Supply Planning Intern (Graduate)

Alexion Pharmaceuticals, Inc. is seeking Master's students for a 10-week internship role at their Boston site. The role involves optimizing routine C&OP outputs, improving data management and dashboarding, and enhancing collaboration between Demand/Supply planning teams and external stakeholders.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Optimize routine C&OP outputs to provide current state updates to leadership
Improve team data management and dashboarding to standardize practices and align outcomes. (Waste/Obsolescence)
Improve ways or working between Demand/Supply planning teams and external stakeholders

Qualification

Data analysisExcelSmartsheetsPowerBIPublic speakingPresentation designCollaborationProject leadership

Required

Master's students majoring in Business, Finance, Pharmacy, Biology, Chemical Engineering, Biotechnology, or a related field
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to the Seaport neighborhood in Boston, MA site 4 days per week

Preferred

Data analysis experience with Excel
Visualization tools experience such as PowerBI
Prior experience leading complex projects and presenting to key stakeholders
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Experience with Smartsheets

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase